Finch Therapeutics Group, Inc.
FNCHCIK 0001733257 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Apr 26, 2024. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0033
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Finch Therapeutics Group, Inc.
| Name | Roles | Filings |
|---|---|---|
| Smisek Jeffery A | Director | 6 |
| Blaustein Marc | Officer | 3 |
| Blischak Matthew P. | Officer | 2 |
| Ferrante Domenic J | Director | 2 |
| Graf Susan E | Director | 2 |
Showing 1-5 of 12
Page 1 of 3Next
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Finch Therapeutics Group, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Smisek Jeffery A | 3 | 100% | +42.9% | +48.1% | +48.1% | +32.4% |
All filings
26 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|